420 with CNW — Study Says Marijuana Legalization Has No Adverse Effects on Outcomes of Army Recruits

Although the country has seen a wave of cannabis reform sweep through its states for the past few years, not everyone is a fan of legal weed. Opponents have claimed that legalizing cannabis would increase drug abuse among the youth and lead to a boost in criminal activity. However, most studies have found that not to be the case, with legal cannabis markets helping people deal with issues such as chronic pain, creating thousands of job opportunities and providing states with millions of dollars in tax revenue.

A new study has found that cannabis use in legal markets has not had a negative effect on army recruits. The Rand Corp study found that despite more states allowing cannabis use, there was little evidence that soldiers coming from such states had negative recruitment outcomes. Researchers arrived at this conclusion after studying regular enlistments for the Army from 2001–2012 and comparing the contracts with Army personnel records up to 2018.

By comparing these two sets of data, the researchers from Rand were able to follow recruits over the years as they progressed in the military. Instead of regular cannabis use before recruitment resulting in worse career outcomes, they found that in some cases, the legalization of cannabis coincided with improved career outcomes for recruits. This means that recruits coming from states that have allowed cannabis use have a reduced likelihood of dropping out before completing their first term, being removed due to their entry-level performance, or failing a physical or medical test.

While 15% of Army recruits in 2001 came from states that allowed medical cannabis, more than half of the 2018 recruits came from states with legal medical cannabis markets while 19% were from states that allowed recreational cannabis use. However, the researchers say that the datasets they used are still incomplete, especially since most states have only recently started to update how they police cannabis.

For instance, the 2017 National Survey on Drug Use and Health found that close to 40% of 18-year-olds have used cannabis at least once in their lives and 20% consumed cannabis in the past month. But from 2001–2018, only 2.5 % of regular Army accessions had a recorded history of cannabis use. Also called a “documented history of marijuana,” this term refers to any and all past encounters with cannabis, including arrests and convictions for using or selling the substance as well as self-confessed cannabis use while being enlisted.

The researchers advise the Army not to lump recruits with only a documented history of marijuana together with recruits who have cannabis-related misconduct offenses on their records.

As more research comes to light dispelling many of the misconceptions around marijuana, savvy companies are poised for explosive growth in the coming years. One such company is Grapefruit USA Inc. (OTCQB: GPFT), which specializes in manufacturing and distributing premium cannabis products in California.

NOTE TO INVESTORS: The latest news and updates relating to Grapefruit USA Inc. (OTCQB: GPFT) are available in the company’s newsroom at http://cnw.fm/GPFT

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Grapefruit USA Inc. (GPFT) Flagship Products Now Available through Key California Mobile Retail Distribution Platform

Grapefruit USA’s (OTCQB: GPFT) patented, disruptive Hourglass(TM) time-release THC+ Cannabinoid delivery cream and full-spectrum RSO cannabis oil are now available on Crown Genetics’ retail delivery online platform. GPFT’s flagship products can be found in the Wellness section and can be purchased in California. This means that consumers living in Los Angeles can order the Hourglass cream of full-spectrum RSO oil online and have it delivered to their homes or offices; once stocked, the products will also be available at 250-plus licensed retailed dispensaries that are serviced by Crown, a leading licensed cannabis distributor in California. The Grapefruit products were only included on the Crown online store and in its retail distribution system after being carefully tested and evaluated. “The approval of Grapefruit’s Hourglass THC/Cannabinoid delivery cream for inclusion on the Crown cannabis product platform represents yet another milestone for our company,” said Grapefruit CEO Bradley Yourist in the press release. “We can think of no more powerful affirmation of Hourglass’ safety and efficacy than to have a company of Crown’s reputation include a product manufactured by an industry peer such as Grapefruit in its menu of offerings to its retail and wholesale clients. Furthermore, Hourglass will now be significantly more available to Los Angeles area residents which should provide a healthy jump start to Hourglass revenues and adoption. Our customers can simply go online to both locate brick and mortar stores that inventory and sell Hourglass or order it online and have it delivered directly to their home or office in California via the Crown delivery system. We anticipate that our inclusion in the Crown system will not only attract many new retail customers for Hourglass and other Grapefruit products but will also expose the ‘Grapefruit’ corporate name, Grapefruit’s trademarked ‘Hourglass name, and our OTCMarkets ticker symbol ‘GPFT’ to an ever-increasing national and international cannabis-centric audience.”

To view the full press release, visit https://cnw.fm/Agwnn

About Grapefruit USA Inc.

Grapefruit’s corporate headquarters is in Westwood, Los Angeles, California. Grapefruit holds California permits and licenses to both manufacture and distribute cannabis products in the Golden State. Grapefruit’s extraction laboratory and manufacturing and distribution facilities are located in the industry-recognized Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, California. To find out more about the company, please visit www.GrapefruitBlvd.com.

NOTE TO INVESTORS: The latest news and updates relating to GPFT are available in the company’s newsroom at https://cnw.fm/GPFT

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — New Study Suggests CBD May Increase Your Lifespan

As 2018 drew to a close, Congress passed a bill that finally legalized industrial hemp after years of prohibition. Among other things, the 2018 Farm Bill legalized the cultivation and sale of industrial hemp plus its extracts. Soon after, demand for a hemp extract called cannabidiol (“CBD”) boomed to immense heights, based mostly on claims that it had extensive medical benefits. Subsequent studies have found CBD to indeed be effective against everything from anxiety, stress, and insomnia to chronic pain and pediatric epilepsy.

While CBD has been proven to be effective against a wide range of medical conditions, does it have the ability to actually increase your lifespan? According to the results of a new study, hemp extract actually may be able to help you live longer. A study by Canopy Group Corporation concluded that worms that consume CBD had a longer lifespan compared to worms that didn’t. Consuming hemp-derived CBD increased the overall lifespan of the worms by 20% and their late-stage activities by 200%.

Additionally, the worms did not exhibit signs of prolonged lifespan toxicity, which refers to the negative side effects of sustained exposure to a stressor. However, note that these results were from an animal study, so more research, specifically on the effect of long-term CBD use by humans, is needed. Still, the fact that cannabidiol increased the worms’ lifespan by 20% without causing any chronic toxicity is impressive.

Nonetheless, translating the methods used in this study for human research will prove difficult. Since worms have a lifespan of only two to three weeks, researchers had enough time to monitor the worms and document how CBD affected their lifespans. On the other hand, humans have a much longer lifespan, making the prospect of studying the long-term effects of CBD consumption on their lifespan more daunting. Fortunately, human and worm genes are quite similar, so the preclinical model used by the Canadian Cannabis Grower’s Association can be used for human studies.

The researchers’ objective was to find out how long-term CBD use affected the worms, especially in regards to solubility, acute toxicity and stability. The researchers found continued CBD use to be safe from any acute toxicity, with none of the worms dying that were exposed to acute CBD. In fact, exposure to concentrated CBD had the opposite effect and extended their lifespans.

A separate study by the University of Bonn looked at the effect of CBD on the memory performance of older mice and found that cannabis had the ability to reverse aging in the brain. Future studies will be needed to concretely prove cannabis’ effect on patients with Alzheimer’s disease.

This research pointing to the potential of CBD to extend human life gives the innovative products of many cannabis companies added value. For example, California-based Grapefruit USA Inc. (OTCQB: GPFT) has technology that makes topically administered CBD more absorbable, thereby increasing the likelihood that a user will get maximum benefit from the cannabis compound.

NOTE TO INVESTORS: The latest news and updates relating to Grapefruit USA Inc. (OTCQB: GPFT) are available in the company’s newsroom at http://cnw.fm/GPFT

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Grapefruit USA Inc. (GPFT) Announces Resignation of Outside Director

Grapefruit USA (OTCQB: GPFT), a premiere, fully licensed California-based cannabis company, today announced the resignation of John M. Hollister. Hollister served as the company’s CEO prior to its reverse acquisition by Grapefruit Boulevard Investments as well as its transition from a developer of 3D imaging to a fully licensed manufacturer and distributor of cannabis products. These include Grapefruit’s patented, disruptive Hourglass(TM) time-release THC/cannabinoid delivery cream. “We are pleased that the previous chapter of the Imaging3/Grapefruit saga has come to an amicable conclusion. While we, of course, will devote the vast majority of our time and energy to our rapidly growing cannabis businesses and to rapidly ushering in the Hourglass era, we intend to take all prudent efforts to maximize the value of our patented 3D imaging technology, whether by sale, development, spinoff or other available methods,” said Bradley J. Yourist, Grapefruit CEO. “With the departure of Mr. Hollister, we intend to immediately commence efforts to populate our board with high-caliber experts who have proven track records in cannabis, public company governance and capital formation.”

To view the full press release, visit https://cnw.fm/sPjOD

About Grapefruit USA Inc.

Grapefruit’s corporate headquarters is in Westwood, Los Angeles, California. Grapefruit holds California permits and licenses to both manufacture and distribute cannabis products in the Golden State. Grapefruit’s extraction laboratory and manufacturing and distribution facilities are located in the industry-recognized Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, located on the extension of North Canyon Road, approximately 14 miles north of downtown Palm Springs. For more information about the company, visit www.GrapefruitBlvd.com.

NOTE TO INVESTORS: The latest news and updates relating to GPFT are available in the company’s newsroom at https://cnw.fm/GPFT

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Legislators in Mexico to Vote on Cannabis Legalization Bill This Week

A vote to legalize cannabis in Mexico is scheduled for this week in the Chamber of Deputies; the vote comes months after the Senate approved the measure. Despite this move, however, legislators state that there’s still no formal revised legislation.

The Political Coordination Board, which was set up by party leaders to agree on various legislative matters, scheduled the proposed bill for floor action on March 9. Martha Tagle Martinez, a member of the chamber’s health committee, stated that there was still no draft opinion, adding that any legislation would have to pass through the Health and Justice Committee where it would be analyzed, discussed, and altered then that draft opinion approved, before it was sent to the floor.

Martinez also revealed that the current legislation that has been approved in the Senate does not fulfill the Supreme Court’s requirement, which had in 2018 judged the prohibition on personal growing and possession of cannabis to be unconstitutional.

Legislators have been charged with ending cannabis criminalization in the country but haven’t done so yet, preferring instead, to repeatedly postpone deadlines to approve the change in policy.

Presently though, the legislature has until the end of April to legalize marijuana in the country.

Last month, the Health Committee held a preliminary discussion on marijuana legalization, with members of the panel declaring that they’d like to hold four sessions to debate the measure. However, those sessions have yet to be convened.

The Senate had approved the marijuana legalization bill earlier in November and sent it to the Chamber of Deputies shortly after. The bill would allow adults aged 18 and above to grow up to six plants for personal use and to buy and possess up to 28 grams of cannabis; the bill would also set up a regulated marijuana market.

Marijuana policy reform advocates across the country are eager for legislators to formally end marijuana prohibition. They are working on convincing the legislature to look into their concerns about some provisions of the current measure, particularly its strict penalties for violation, the limited nature of the bill’s social equity components and the proposed registry for self-cultivators. In addition to this, activists also want to increase the percentage of licenses given to individuals who had been affected by prohibition.

In an op-ed coauthored by Amaya Ordorika Imaz, the co-ordinator of the ReverdeSer Colectivo, and ZaraSnapp of #RegulacionPorLaPaz and Instituto RIA, noted that incorporating a social justice outlook was necessary because it would help encourage the growth of an inclusive and horizontal market that promoted fair conditions for communities in vulnerable situations and dignified participation while also steering clear of the formation of corporate oligopolies.

Back on U.S. soil, lots of companies are thriving in jurisdictions with legal marijuana markets. For example, Grapefruit USA Inc. (OTCQB: GPFT) operates the Rainbow Dreams brand through which the company serves the recreational cannabis market with premium products capitalizing on natural flavors and rare cannabis strains.

NOTE TO INVESTORS: The latest news and updates relating to Grapefruit USA Inc. (OTCQB: GPFT) are available in the company’s newsroom at http://cnw.fm/GPFT

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Virginia Becomes 16th State to Legalize Recreational Cannabis

Virginia’s Legislature recently passed a measure that would legalize adult-use cannabis in the state. The Senate passed the initiative in a 20–19 vote while the House approved it in a 48–43 vote, making Virginia the only state in the Old South to allow legalization. It should be noted that not one Republican in either chamber voted for the measure.

Democratic Majority Leader Del. Charniele Herring, who sponsored the measure, stated on the floor that to her, the legislation was a justice bill, adding that while it still had flaws, it represented a step in the right direction.

While cannabis sales will not begin until 2024, Virginia is now the 16th state in America to approve an adult-use cannabis legalization bill. Apart from Virginia, Vermont and Illinois are the two other states that have approved bills to regulate, tax and legalize recreational cannabis through the legislature.

Under the compromise bill, cannabis for recreational use would still not be legal until January 2024, when regulated sales are scheduled to commence. The state will establish a cannabis regulatory agency this July.

Earlier in April 2020, the state’s Governor Ralph Northam approved a legislation that decriminalized cannabis possession, with the law taking effect on July 1 last year. Legislators approved a legislation this session that would broaden the state’s medical cannabis program to permit cannabis flower products. The first medical cannabis dispensary in the state was launched in August 2020.

Gov. Northam stated last year that he supported legalization, urging legislators to approve his proposal during his state of the state address. The bill was based off of a pair of comprehensive studies on the issue: a report from the independent Joint Legislative Audit and Review Committee and his administration’s report on the matter.

The measures made their rounds in the chambers, with legislators addressing various issues, including how to handle automatic expungements of cannabis offenses and how to prevent big corporations from monopolizing the cannabis market in the state.

The legislation encompasses strong social equity provisions, which include the prioritization of business licenses for people considered to have been disproportionately affected by criminal enforcement. The bill would also permit individuals who are 21 years or older to possess up to an ounce of cannabis, while also allowing individuals to grow up to four plants per household.

Additionally, the bill imposes a 21% excise tax on cannabis, with the tax revenues generated being directed to fund substance use disorder treatment programs, prekindergarten education and other public health initiatives.

Meanwhile, other states that legalized cannabis earlier are also seeing the list of successful industry players growing. For example, Grapefruit USA Inc. (OTCQB: GPFT), based in California, excels at manufacturing cannabis distillates using the ethanol extraction method, and these distillates find use in lots of different applications, such as in tinctures and cannabis-infused edibles.

NOTE TO INVESTORS: The latest news and updates relating to Grapefruit USA Inc. (OTCQB: GPFT) are available in the company’s newsroom at http://cnw.fm/GPFT

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Surging Patient Numbers Trigger Hiring Spree in Florida’s Medical Marijuana Sector

In 2020 alone, Florida’s medical cannabis program created approximately 15,000 jobs, and a new analysis revealed that, in total, approximately 31,450 Florida residents are now employed in this industry.

A report authored by Leafly & Whitney Economics shows that the total sales of cannabis last year was valued at $1.23 billion. These statistics show that Florida outdid every state with a legal marijuana program except Colorado and California, where robust adult-use programs exist.

According to the Office of Medical Marijuana, the state agency charged with overseeing medical cannabis in Florida, a total of 170,000 people registered as medical marijuana patients in 2020 in Florida. This number brought the total of active card holders within the state to 485,693. That growth is projected to retain its momentum to an extent that annual sales may hit the $6 billion mark every year between now and 2030.

That notwithstanding, Leafly & Whitney Economics experts are of the opinion that those numbers would pale if the state opted to establish a recreational cannabis program, or at least get rid of the cumbersome and even potentially unconstitutional way in which medical marijuana is currently regulated.

Since the state has a population of approximately 22 million residents, an adult-use mechanism would swiftly double the number of people consuming marijuana. Subsequently, sales would surge to $2.1 billion each year, and taxes for both the state and local governments would total $800 million a year.

One of the regulations that is contentious in the current medical marijuana law stipulates that state regulators can issue up to 22 licenses to vertically integrated entities, or those that can handle marijuana from seed to the time products are sold. A Tallahassee appeals court declared this provision unconstitutional, and the Supreme Court of Florida is set to hear this case early next month.

However, state legislators aren’t waiting for the highest court in the state to pronounce itself on this matter; they are taking a legislative route to reform the system. For example, SB562 and HB593 are aimed at stopping retail outlets from manufacturing the medical marijuana products that they sell. In other words, the vertical integration under the existing law would be rolled back.

Each of those bills is expected to go through a total of four committees before a floor vote is scheduled, and none of the requisite committees has indicated when it will discuss the bill before it. However, Senate President Wilton Simpson says that another bill that could put a cap on THC concentrations in marijuana products is likely to be discussed soon. This particular bill was vehemently opposed by veterans as well as key Republican members of Florida’s Senate. It remains to be seen how all those bills will fare.

As cannabis gains momentum around the world, companies such as Grapefruit USA Inc. (OTCQB: GPFT) are on course to grab a big share of the market before others whose product range isn’t as unique.

NOTE TO INVESTORS: The latest news and updates relating to Grapefruit USA Inc. (OTCQB: GPFT) are available in the company’s newsroom at http://cnw.fm/GPFT

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — CBD Added to EU Database of Accepted Cosmetic Ingredients

Although cannabidiol (“CBD”) has enjoyed immense popularity in the past couple of years, the hemp extract is still barely regulated in most territories. In the United States, different states have different CBD regulations, and the situation isn’t any different in Europe. However, the European Union has moved a step closer towards standard legislation after CBD was added as a cosmetic ingredient in the EU’s database.

The EU’s Directorate-General for Internal Market, Industry, Entrepreneurship, and SMEs added CBD to its CosIng guidelines as a cosmetic ingredient. This revision to the guidelines comes after the Court of Justice of the European Union (“CJEU”) ruled that under the UN Single Convention on Narcotic Drugs of 1961, cannabidiol extracted from the hemp plant in its entirety is not a narcotic. Consequently, the court ruled that CBD should be traded between the Union’s member states freely.

Before the revision, only synthetic CBD was allowed as a cosmetic ingredient. The CosIng guidelines are a database of cosmetic regulations that identify legal and illegal ingredients and define their functions and benefits. Now that CBD derived from the hemp plant has been added to the list, it can be used as a cosmetic ingredient as an anti-sebum, skin protectant, skin conditioner and antioxidant.

At the moment, CBD regulations differ wildly among member states, leading to a patchwork of regulation across the EU. For instance, some countries allow up to 1% THC in CBD cosmetic products while others are more punitive and do not allow any THC. On top of that, different countries also have different requirements for manufacturing, labeling and marketing CBD cosmetic products. This patchwork of regulations forces manufacturers and distributors to adhere to different rules and regulations in each country in which they transact, essentially preventing these companies from trading their goods freely within the European Union.

The CosIng guidelines may not be legally binding, but they serve as a guide for EU member states when they craft their own cosmetic product regulations. The guidelines aim to bolster the creation of standardized CBD regulations across the EU to allow free movement of CBD cosmetics. The revision is a small but definite step towards achieving a standard regulatory framework for CBD in the European Union. What is definitely legally binding on all member states, however, is the CJEU ruling that came out before the revision to the regulations.

Due to the historic ruling, all European governments that were keeping companies from marketing and selling CBD cosmetics will have to amend the cannabidiol regulations.

Still on the subject of CBD, lots of exciting innovations are happening in this space. An example is Grapefruit USA Inc. (OTCQB: GPFT). Grapefruit harnesses advanced science and technology to bring patented products to the cannabis marketplace. The company is revolutionizing the way people use THC, CBDs and hemp-derived CBDs while also capitalizing on the surging demand for these unique products.

NOTE TO INVESTORS: The latest news and updates relating to Grapefruit USA Inc. (OTCQB: GPFT) are available in the company’s newsroom at http://cnw.fm/GPFT

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Grapefruit USA Inc. (GPFT) Obtains California Trademark Protection for Flagship Hourglass Cream

Grapefruit USA (OTCQB:GPFT), a premiere, fully licensed California-based cannabis company, announced that it has secured trademark protection for its Hourglass name and logo. The now-protected name and logo are used on Grapefruit’s patented disruptive Hourglass(TM) THC/cannabinoid time-release delivery cream. With the approved trademark, the Hourglass name and logo are now categorized as protected intellectual property rights of Grapefruit USA Inc. That status means that no other company operating in the cannabis space can use the property; the announcement noted that Grapefruit also possesses common-law, first-in-time, trademark protection to Hourglass. In addition, the company has secured California trademark and service mark protections for the Grapefruit corporate name and other product lines including Sugar Stoned and Rainbow Dreams. The company intends to obtain federal trademark protection when the federal government legalizes cannabis. “Obtaining our California trademark protection for Hourglass is pivotal for us to protect our intellectual property rights and goodwill with respect to Grapefruit’s Hourglass line of products,” said Grapefruit CEO Bradley J. Yourist in the press release. “It is only fitting that Grapefruit has exclusive rights to the Hourglass name and logo since Grapefruit has an exclusive license for use of the patented technology upon which the Hourglass time release delivery cream is based and is the only enterprise on earth with the technical know-how to manufacture the Hourglass delivery cream for the regulated cannabis market. That symmetry is exquisite. Securing our trade name is another step forward in the dawning of the Hourglass Era. Hourglass products may only be obtained from Grapefruit and its authorized agents.”

To view the full press release, visit https://cnw.fm/Nnb0Y

About Grapefruit USA Inc.

NOTE TO INVESTORS: The latest news and updates relating to GPFT are available in the company’s newsroom at https://cnw.fm/GPFT

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Iowa Legislators Pass Bill Slashing Fees Paid by Medical Cannabis Patients

Thanks to a new bill advancing in the Iowa Senate, Iowans may soon be paying only $10 every year in medical cannabis license fees instead of the $100 a year they currently pay. The bill will also allow the licensing of more medical cannabis dispensaries beyond the five currently allowed by law as well as the creation of mobile dispensaries to cater to the state’s medical marijuana patients. Additionally, Senate Bill 1177 will allow medical cannabis dispensaries to recommend physicians who can prescribe medical cannabis to patients, something current law prohibits.

However, a subcommittee of the Senate noted that lawmakers will have to make changes to the fees and other sections of this bill to ensure the medical cannabis program receives enough revenue to cover state administration as well as testing. The Department of Public Health together with the University of Iowa, which runs the State Hygienic Laboratory, have said via representatives that without any changes, cutting medical cannabis card fees from $100 a year down to $10 every two years will leave them with insufficient revenue to run the program.

On top of drastically reducing medical cannabis card fees, the bill will also cut the fees incurred by medical cannabis manufacturers down to $2,000 annually. It will instead create income tax deductions for business-related expenses linked to manufacturing medical cannabis. According to Dane Schumann, from the medical cannabis manufacturer and dispenser MedPharm Iowa, state manufacturers have so far paid in excess of half a million dollars’ worth of fees to Iowa’s Department of Public Health ever since the program was launched, with dispensaries paying a similar sum.

Generally, manufacturers as well as dispensaries pay hefty fees to the state health department, Schumann says, even though state operators such as MedPharm need to keep overhead costs manageable to make sure that the program keeps running. Last year, medical cannabis sales totaled around $5 million, which is an increase from the $2.2 million recorded the year before. At current sales levels, a 6% tax would produce $210,000 annually.

Senator Joe Bolkcom, who supports the bill, notes that lawmakers initially intended for the program to be self-sustaining when they created it. At the moment, the state Department of Health receives between $600,000 and $700,000 each year to run the medical cannabis program, and lawmakers wouldn’t wish to eat into other segments of its operations to meet the cost of the program, he says. So while the $100 a year fee for medical cannabis cards was too high, he believes the proposed $10 paid after every two years is too low to afford the program’s running costs.

Meanwhile, many companies have realized that a significant number of consumers are interested in cannabis products containing THC, the psychoactive compound responsible for the “high” users experience. For example, Grapefruit USA Inc. (OTCQB: GPFT) is planning to nationally distribute its patented Hourglass Topical Cream made from hemp.

NOTE TO INVESTORS: The latest news and updates relating to Grapefruit USA Inc. (OTCQB: GPFT) are available in the company’s newsroom at http://cnw.fm/GPFT

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork